Clinical study of prenatal ultrasonography combined with T‑box transcription factor 1 as a biomarker for the diagnosis of congenital heart disease

Guo,Bingcheng; Xiao,Jing; Li,Long; Wang,Shuanglong; Wang,Lijuan; Liu,Shuyong

doi:10.3892/mmr.2018.8742

Clinical study of prenatal ultrasonography combined with T‑box transcription factor 1 as a biomarker for the diagnosis of congenital heart disease

Authors:
- Bingcheng Guo
- Jing Xiao
- Long Li
- Shuanglong Wang
- Lijuan Wang
- Shuyong Liu
View Affiliations

Affiliations: Department of Ultrasound, Jining No. 1 People's Hospital, Jining, Shandong 272011, P.R. China, Department of Hand and Foot Surgery, Jining No. 1 People's Hospital, Jining, Shandong 272011, P.R. China
Published online on: March 14, 2018 https://doi.org/10.3892/mmr.2018.8742
Pages: 7346-7350

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Congenital heart disease (CHD) seriously threatens fetal health. Therefore, prenatal examination to detect deformity is extremely important. The present study aimed to investigate the clinical application value of prenatal ultrasonography combined with molecular biology methods in the diagnosis of fetal CHD. A total of 1,000 pregnant women who had received fetal ultrasonography to examine fetal CHD were enrolled. Ultrasounds were performed for fetal heart examination and diagnosis, mainly on fetal heart position, size, structure and function, and heart valve morphology and function. These indexes were tested again 2 weeks after birth. Blood samples were collected from pregnant women with fetal CHD. Polymerase chain reaction (PCR) and western blotting were performed to detect the association between heart development and T‑box transcription factor 1 (TBX1) expression. The results revealed that 10 fetuses had CHD (1%), of which ultrasound detected 9 cases. The specificity and sensitivity of ultrasounds were 100 and 90%, respectively. Of the 9 cases were identified by prenatal ultrasound screening, including 2 cases had endocardial cushion defect, 1 case had pulmonary stenosis combined with right ventricular dysplasia, 1 case had tetralogy of Fallot combined with a cleft lip and palate, 2 cases had ventricular septal defect, 1 case had a single ventricle defect, 1 case had Ebstein and 1 case had a triatrial heart. One case of ventricular septal defect was missed prior to delivery. PCR and western blotting demonstrated that TBX1 expression may be associated with CHD. Therefore, ultrasonography combined with laboratory examinations represent efficient, economic and safe methods for fetal CHD detection. These methods may be significant to improve the rate of CHD diagnosis, and require further investigation.

View Figures

View References

1	Sargos P, Guerif S, Latorzeff I, Hennequin C, Pommier P, Lagrange JL, Crehange G, Chapet O, de Crevoisier R, Azria D, et al: Definition of lymph node areas for radiotherapy of prostate cancer: A critical literature review by the French Genito-Urinary Group and the French Association of Urology (GETUG-AFU). Cancer Treat Rev. 41:814–820. 2015. View Article : Google Scholar : PubMed/NCBI
2	Nicholson A, Mahon J, Boland A, Beale S, Dwan K, Fleeman N, Hockenhull J and Dundar Y: The clinical effectiveness and cost-effectiveness of the PROGENSA(R) prostate cancer antigen 3 assay and the prostate health index in the diagnosis of prostate cancer: A systematic review and economic evaluation. Health Technol Assess. 19(i–xxxi): 1–191. 2015. View Article : Google Scholar
3	Woodrum DA, Kawashima A, Gorny KR and Mynderse LA: Magnetic resonance-guided thermal therapy for localized and recurrent prostate cancer. Magn Reson Imaging Clin N Am. 23:607–619. 2015. View Article : Google Scholar : PubMed/NCBI
4	Ahmad AE and Finelli A: Should prebiopsy multiparametric magnetic resonance imaging be offered to all Biopsy-naïve men undergoing prostate biopsy? Eur Urol. 69:426–427. 2016. View Article : Google Scholar : PubMed/NCBI
5	Westphalen AC, Noworolski SM, Harisinghani M, Jhaveri KS, Raman SS, Rosenkrantz AB, Wang ZJ, Zagoria RJ and Kurhanewicz J: High-resolution 3-T endorectal prostate MRI: A multireader study of radiologist preference and perceived interpretive quality of 2D and 3D T2-weighted fast Spin-Echo MR images. AJR Am J Roentgenol. 206:86–91. 2016. View Article : Google Scholar : PubMed/NCBI
6	Amanullah MM, Hamid M, Hanif HM, Muzaffar M, Siddiqui MT, Adhi F, Ahmad K, Khan S and Hasan Z: Effect of steroids on inflammatory markers and clinical parameters in congenital open heart surgery: A randomised controlled trial. Cardiol Young. 26:506–515. 2016. View Article : Google Scholar : PubMed/NCBI
7	Liu C, Shen A, Li X, Jiao W, Zhang X and Li Z: T-box transcription factor TBX20 mutations in Chinese patients with congenital heart disease. Eur J Med Genet. 51:580–587. 2008. View Article : Google Scholar : PubMed/NCBI
8	Butler TL, Esposito G, Blue GM, Cole AD, Costa MW, Waddell LB, Walizada G, Sholler GF, Kirk EP, Feneley M, et al: GATA4 mutations in 357 unrelated patients with congenital heart malformation. Genet Test Mol Biomarkers. 14:797–802. 2010. View Article : Google Scholar : PubMed/NCBI
9	Kirk EP, Sunde M, Costa MW, Rankin SA, Wolstein O, Castro ML, Butler TL, Hyun C, Guo G, Otway R, et al: Mutations in cardiac T-box factor gene TBX20 are associated with diverse cardiac pathologies, including defects of septation and valvulogenesis and cardiomyopathy. Am J Hum Genet. 81:280–291. 2007. View Article : Google Scholar : PubMed/NCBI
10	Zhang Y, Han Q, Li C, Li W, Fan H, Xing Q and Yan B: Genetic analysis of the TBX1 gene promoter in indirect inguinal hernia. Gene. 535:290–293. 2014. View Article : Google Scholar : PubMed/NCBI
11	Töpf A, Griffin HR, Glen E, Soemedi R, Brown DL, Hall D, Rahman TJ, Eloranta JJ, Jüngst C, Stuart AG, et al: Functionally significant, rare transcription factor variants in tetralogy of Fallot. PLoS One. 9:e954532014. View Article : Google Scholar : PubMed/NCBI
12	Monroy-Muñoz IE, Pérez-Hernández N, Rodríguez-Pérez JM, Muñoz-Medina JE, Angeles-Martínez J, García-Trejo JJ, Morales-Ríos E, Massó F, Sandoval-Jones JP, Cervantes-Salazar J, et al: Novel mutations in the transcriptional activator domain of the human TBX20 in patients with atrial septal defect. Biomed Res Int. 2015:7187862015. View Article : Google Scholar : PubMed/NCBI
13	Chen J, Sun F, Fu J and Zhang H: Association of TBX20 gene polymorphism with congenital heart disease in Han Chinese neonates. Pediatr Cardiol. 36:737–742. 2015. View Article : Google Scholar : PubMed/NCBI
14	Lin SB, Xie YJ, Chen Z, Zhou Y, Wu JZ, Zhang ZQ, Shi SS, Chen BJ and Fang Q: Improved assay performance of single nucleotide polymorphism array over conventional karyotyping in analyzing products of conception. J Chin Med Assoc. 78:408–413. 2015. View Article : Google Scholar : PubMed/NCBI
15	Henderson DR, de Souza NM, Thomas K, Riches SF, Morgan VA, Sohaib SA, Dearnaley DP, Parker CC and van As NJ: Nine-year follow-up for a study of diffusion-weighted magnetic resonance imaging in a prospective prostate cancer active surveillance cohort. Eur Urol. 69:1028–1033. 2016. View Article : Google Scholar : PubMed/NCBI
16	You JY, Lee HJ, Hwang SI, Bae YJ, Kim H, Hong H and Choe G: Value of T1/T2-weighted magnetic resonance imaging registration to reduce the postbiopsy hemorrhage effect for prostate cancer localization. Prostate Int. 3:80–86. 2015. View Article : Google Scholar : PubMed/NCBI
17	Biglino G, Capelli C, Wray J, Schievano S, Leaver LK, Khambadkone S, Giardini A, Derrick G, Jones A and Taylor AM: 3D-manufactured patient-specific models of congenital heart defects for communication in clinical practice: Feasibility and acceptability. BMJ Open. 5:e0071652015. View Article : Google Scholar : PubMed/NCBI
18	Li X, Sundquist J, Hamano T, Zoller B and Sundquist K: Neighbourhood deprivation, individual-level and familial-level socio-demographic factors and risk of congenital heart disease: A nationwide study from Sweden. Int J Behav Med. 23:112–120. 2016. View Article : Google Scholar : PubMed/NCBI
19	Gaynor JW, Stopp C, Wypij D, Andropoulos DB, Atallah J, Atz AM, Beca J, Donofrio MT, Duncan K, Ghanayem NS, et al: Neurodevelopmental outcomes after cardiac surgery in infancy. Pediatrics. 135:816–825. 2015. View Article : Google Scholar : PubMed/NCBI
20	Kwiatkowski D, Czarny P, Galecki P, Bachurska A, Talarowska M, Orzechowska A, Bobińska K, Bielecka-Kowalska A, Pietras T, Szemraj J, et al: Variants of base excision repair genes MUTYH, PARP1 and XRCC1 in Alzheimer's disease risk. Neuropsychobiology. 71:176–186. 2015. View Article : Google Scholar : PubMed/NCBI
21	Knopp C, Rudnik-Schöneborn S, Eggermann T, Bergmann C, Begemann M, Schoner K, Zerres K and Ortiz Brüchle N: Syndromic ciliopathies: From single gene to multi gene analysis by SNP arrays and next generation sequencing. Mol Cell Probes. 29:299–307. 2015. View Article : Google Scholar : PubMed/NCBI
22	Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA, Del Nido P, Fasules JW, Graham TP Jr, Hijazi ZM, et al: ACC/AHA 2008 Guidelines for the management of adults with congenital heart disease: Executive summary: A report of the American college of cardiology/american heart association task force on practice guidelines (writing committee to develop guidelines for the management of adults with congenital heart disease). Circulation. 118:2395–2451. 2008. View Article : Google Scholar : PubMed/NCBI
23	Weaver JK, Kim EH, Vetter JM, Fowler KJ, Siegel CL and Andriole GL: Presence of magnetic resonance imaging suspicious lesion predicts gleason 7 or greater prostate cancer in Biopsy-Naive patients. Urology. 88:119–124. 2016. View Article : Google Scholar : PubMed/NCBI
24	Tay KJ, Gupta RT, Brown AF, Silverman RK and Polascik TJ: Defining the incremental utility of prostate multiparametric magnetic resonance imaging at standard and specialized read in predicting extracapsular extension of prostate cancer. Eur Urol. 70:211–213. 2016. View Article : Google Scholar : PubMed/NCBI
25	Wang YJ, Huang CY, Hou WH, Wang CC, Lan KH, Chen CH, Yu HJ, Lai MK, Cheng AL, Liu SP, et al: The outcome and prognostic factors for lymph node recurrence after node-sparing definitive external beam radiotherapy for localized prostate cancer. World J Surg Oncol. 13:3122015. View Article : Google Scholar : PubMed/NCBI
26	Engelhard K, Kühn R, Osten A, Bogner K, Dworak A, Lübke L and Schneider F: Impact of magnetic resonance imaging-guided prostate biopsy in the supine position on the detection of significant prostate cancer in an inhomogeneous patient cohort. Scand J Urol. 50:110–115. 2016. View Article : Google Scholar : PubMed/NCBI
27	Thompson JE, van Leeuwen PJ, Moses D, Shnier R, Brenner P, Delprado W, Pulbrook M, Böhm M, Haynes AM, Hayen A and Stricker PD: The diagnostic performance of multiparametric magnetic resonance imaging to detect significant prostate cancer. J Urol. 195:1428–1435. 2016. View Article : Google Scholar : PubMed/NCBI
28	Jia JB, Houshyar R, Verma S, Uchio E and Lall C: Prostate cancer on computed tomography: A direct comparison with multi-parametric magnetic resonance imaging and tissue pathology. Eur J Radiol. 85:261–267. 2016. View Article : Google Scholar : PubMed/NCBI
29	Wang S, Fan X, Medved M, Pineda FD, Yousuf A, Oto A and Karczmar GS: Arterial input functions (AIFs) measured directly from arteries with low and standard doses of contrast agent, and AIFs derived from reference tissues. Magn Reson Imaging. 34:197–203. 2016. View Article : Google Scholar : PubMed/NCBI